Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis.
about
Sphingosine 1-phosphate induces filopodia formation through S1PR2 activation of ERM proteinsExploring the full spectrum of macrophage activationFrom Inflammation to Prostate Cancer: The Role of InflammasomesInflammation in gastric cancer: Interplay of the COX-2/prostaglandin E2 and Toll-like receptor/MyD88 pathwaysSTING: infection, inflammation and cancerThe role of macrophages and dendritic cells in the initiation of inflammation in IBDThe Yin and Yang of Toll-like receptors in cancerModeling cell-in-cell structure into its biological significanceMultiple roles of toll-like receptor 4 in colorectal cancerTumor associated macrophage: a review on the phenotypes, traits and functionsMicrobiome, inflammation, and cancerImmunity, Inflammation, and CancerMyD88: a central player in innate immune signalingAnti-ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti-PD-1 or anti-CD137 mAb therapyDangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancerMacrophage diversity enhances tumor progression and metastasisToll-like receptor signaling in cell proliferation and survivalCell-in-cell phenomenon: A New Paradigm in Life Sciences.High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer.Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasisxCT deficiency accelerates chemically induced tumorigenesis.Downregulation of adaptor protein MyD88 compromises the angiogenic potential of B16 murine melanoma.IL-23 suppresses innate immune response independently of IL-17A during carcinogenesis and metastasis.Toll-Like Receptors and Cancer: MYD88 Mutation and Inflammation.Tumor-primed, in vitro-activated CD4+ effector T cells establish long-term memory without exogenous cytokine support or ongoing antigen exposureTLR4-mediated skin carcinogenesis is dependent on immune and radioresistant cells.MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18The localization and density of immune cells in primary tumors of human metastatic colorectal cancer shows an association with response to chemotherapyDual function of MyD88 in RAS signaling and inflammation, leading to mouse and human cell transformationInflammasome activation is critical to the protective immune response during chemically induced squamous cell carcinoma.Tumor microenvironment macrophage inhibitory factor directs the accumulation of interleukin-17-producing tumor-infiltrating lymphocytes and predicts favorable survival in nasopharyngeal carcinoma patients.CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivationPresence of S100A9-positive inflammatory cells in cancer tissues correlates with an early stage cancer and a better prognosis in patients with gastric cancer.From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation.Recognition of tumors by the innate immune system and natural killer cells.Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase.Hypoxia-induced autophagic response is associated with aggressive phenotype and elevated incidence of metastasis in orthotopic immunocompetent murine models of head and neck squamous cell carcinomas (HNSCC).Gene expression analysis of peripheral blood cells reveals Toll-like receptor pathway deregulation in colorectal cancerOverexpression of the toll-like receptor (TLR) signaling adaptor MYD88, but lack of genetic mutation, in myelodysplastic syndromes.Interplay between DNA repair and inflammation, and the link to cancer
P2860
Q24302055-B82E5A9D-C49F-4700-B706-BB78DC10DCC6Q24653754-F94B7C54-4AD0-4050-A013-33888EA0E4CBQ26739947-A4262B3A-275E-4DCF-BC39-04C9AE514085Q26748123-5712ABEE-55DA-4B0B-8685-F25CE56DA341Q26776009-7AA97C29-D37E-4A8C-A264-1F487A829C34Q26827408-19980A9D-595B-47AC-B939-93E13304F169Q26851526-AD9BD002-C015-4E09-B598-8A421AFB0472Q26997086-0AEB464E-F1F5-495F-818C-21A9E104CF72Q27008380-88D5EC0F-5003-4099-A290-D2DDA78F8608Q27010428-09305FAC-4F21-4BA6-8B61-B486B9D45393Q27027582-9A9E1C80-E7E4-44B5-A519-EE3A7AF6F142Q27861048-A851B855-50BB-439F-B364-39A6523E459FQ28087307-05CA15AD-20C2-4B97-B53D-410792A9A068Q28235277-CA8EECD8-DBAB-44F8-823D-BDEE3ECADA6AQ28267996-E9E13EAD-A0BB-4D1E-BCC1-153A75820CEEQ29615847-2F02E16C-1D16-45BC-A07A-BF5616B28C01Q33598805-6DDBBA5D-A2ED-44C0-A3EF-A9A22453BB2DQ33600369-7F159DA6-CC8C-4B8E-9490-F465558BD5FEQ33708134-DB6E2FAA-1AEB-476A-9F30-1258D11BC15AQ33762632-395E2D87-1789-4A3B-A643-6EEED1CCE8EFQ33779032-9D52DA45-5221-437B-96DC-59E3E5496E07Q33853103-489DA1D2-E0D6-4EF4-B938-F27325C86DDFQ33929197-AC439776-18DC-4F50-B7C3-709FB3ED962AQ33978723-2B8F1255-8B42-46E4-B4F8-C22E913A8AACQ33993999-32E061DD-E120-4332-9A12-FC7DDB1F58C1Q34000194-782B0BE1-FED7-4440-AB0E-28255C6AADC1Q34044424-0E42FB72-F38A-435B-BC0E-B6ED281DA1AFQ34111824-A68EFD02-F9C8-4E1C-9661-9E79D01FC710Q34162163-45BB447E-74EC-4F17-A488-CFE49538BAABQ34275796-F679DD05-CC77-464D-A5B6-53CC5B762E7BQ34294055-54AA32BD-55D1-4009-927D-D7B05A104839Q34346803-4E6CA5BF-278D-4139-BDF3-2154B7A99420Q34354001-9F56044C-6BF1-4CC1-849F-3ADE50F17CCCQ34359869-4E13C641-4E53-4DE8-833D-176314FE134EQ34496462-F62DFB33-BDD3-4CEB-A784-CB8784DFF32DQ34657500-08DE727D-07A4-4B05-B931-15C3D8FE2851Q34671206-E49AC455-72B8-4C72-8E59-5C5EFBE53938Q34708456-040CE330-1343-4EE7-9494-43B0125E9A05Q34970662-46FB8AD2-389A-4393-A6D6-169EED97F767Q34989590-6DDED959-8270-487F-897D-7DE13EB477FD
P2860
Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Demonstration of inflammation- ...... during primary tumorigenesis.
@ast
Demonstration of inflammation- ...... during primary tumorigenesis.
@en
type
label
Demonstration of inflammation- ...... during primary tumorigenesis.
@ast
Demonstration of inflammation- ...... during primary tumorigenesis.
@en
prefLabel
Demonstration of inflammation- ...... during primary tumorigenesis.
@ast
Demonstration of inflammation- ...... during primary tumorigenesis.
@en
P2093
P2860
P356
P1476
Demonstration of inflammation- ...... during primary tumorigenesis.
@en
P2093
Anabel Silva
Janelle Sharkey
Jeremy B Swann
Robert D Schreiber
Shizuo Akira
P2860
P304
P356
10.1073/PNAS.0708594105
P407
P577
2008-01-04T00:00:00Z